< 1/ 1 000) се наблюдават белодробни нежелани реакции, по- специално интерстициална пневмония.
au Rare (≥ 1/ 10,000 to < 1/ 1,000) pulmonary adverse effects, in particular interstitial pneumonia, have been reported after G-CSF administration.